跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 518 条关于
“Kaerus”
全部
518
临床试验
408
药物
37
机构
22
资讯
51
去年
Kaerus Bioscience's KER-0193 Receives FDA Orphan and Rare Pediatric Drug Designations for Fragile X Syndrome
去年
Servier Acquires KER-0193 for $450M to Target Fragile X Syndrome, Marking First Neurology Asset
10个月前
Abivax Phase III Success Triggers 850% Stock Surge, Reignites European Biotech Rally
去年
FDA Approves Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic and Non-Small Cell Lung Cancers
去年
Kairos Pharma Advances Oncology Therapeutics with ENV105 in Clinical Trials
去年
FDA Extends PDUFA Date for Merus' Zenocutuzumab BLA to February 2025
去年
Gilead Sciences Settles Patent Dispute with Laurus Labs Over HIV Drug Tenofovir
去年
FDA Gears Up for Key Decisions on Rosacea, Lung Cancer, AADC Deficiency, and ALL Therapies
去年
Merus Advances Petosemtamab and Zenocutuzumab in Phase III Trials for Head and Neck Cancer and NRG1+ Cancers
去年
Cerus Highlights INTERCEPT Blood System Advancements at AABB 2024
第 1 页,共 6 页
上一页
下一页